Clinical Trials Directory

Trials / Completed

CompletedNCT03961464

The Effect of D-cycloserine on Emotional Processing

The Effect of NMDA Receptor Partial Agonist D-cycloserine on Emotional Processing, Stress and Memory in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

To investigate the effects of N-methyl-D-aspartate (NMDA) partial agonist DCS on emotional processing, memory and stress tasks

Detailed description

The aim of the present study is to assess the effect of DCS on emotional processing relevant to antidepressant drug activity. For this, 40 healthy volunteers will be recruited to the study and randomized to receive a single session of 250mg DCS or placebo. 3 hours and 24 hours after active drug/placebo administration, the effects of emotional processing via the use of cognitive tasks will be assessed. Also, given the important role of DCS in memory and stress, we also include tasks to explore changes in autobiographical memory and in psychological and physiological measures of stress and arousal.

Conditions

Interventions

TypeNameDescription
DRUGd-cycloserineSingle dose
DRUGPlaceboSingle dose

Timeline

Start date
2018-08-10
Primary completion
2018-12-05
Completion
2018-12-05
First posted
2019-05-23
Last updated
2019-05-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03961464. Inclusion in this directory is not an endorsement.